We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Updates Recommendations for Influenza Vaccine Applications
EMA Updates Recommendations for Influenza Vaccine Applications
Manufacturers of influenza vaccines may obtain marketing authorization in the EU based on less-than-comprehensive applications if they supplement their filings with clinical trial data after a pandemic is declared, the European Medicines Agency says.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor